Detalles de la búsqueda
1.
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications.
Clin Gastroenterol Hepatol
; 22(4): 789-797.e8, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048934
2.
Chronic activation of ß-adrenergic receptors leads to tissue water and electrolyte retention.
J Pharmacol Exp Ther
; 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38849140
3.
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.
Liver Int
; 44(1): 113-124, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37789669
4.
Higher Indocyanine Green Retention Is Associated with Improved Prognosis in Patients with Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.
J Vasc Interv Radiol
; 35(3): 428-436, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37967647
5.
Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.
BMC Gastroenterol
; 24(1): 123, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561671
6.
Effects of D-allose on ATP production and cell viability in neonatal rat cardiomyocytes.
J Pharmacol Sci
; 154(4): 274-278, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485345
7.
Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021.
Hepatol Res
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38638067
8.
Kinetics of the hepatitis B core-related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide.
Hepatol Res
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685853
9.
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Hepatol Res
; 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661715
10.
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Hepatol Res
; 54(4): 382-391, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37983642
11.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Clin Gastroenterol Hepatol
; 21(2): 370-379, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051649
12.
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
Oncology
; 101(9): 542-552, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552968
13.
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Oncology
; 101(4): 270-282, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455517
14.
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
Oncology
; 101(10): 624-633, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307798
15.
Validation of fatty liver index as a predictor of hepatic steatosis in Asian populations: Impact of alcohol consumption and sex.
Hepatol Res
; 53(10): 968-977, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300349
16.
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(6): 489-496, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807720
17.
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study.
Hepatol Res
; 53(4): 312-321, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36524984
18.
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(5): 391-400, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707103
19.
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study.
Hepatol Res
; 53(11): 1059-1072, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537735
20.
Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
Hepatol Res
; 53(1): 51-60, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36136893